These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29497899)

  • 1. Predictive value of microRNA-132 and its target gene NAG-1 in evaluating therapeutic efficacy of non-steroidal anti-inflammatory drugs treatment in patients with ankylosing spondylitis.
    Guo TM; Yan Y; Cao WN; Liu Q; Zhu HY; Yang L; Gao MC; Xing YL
    Clin Rheumatol; 2018 May; 37(5):1281-1293. PubMed ID: 29497899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration.
    Huang CH; Wei JC; Chang WC; Chiou SY; Chou CH; Lin YJ; Hung PH; Wong RH
    J Rheumatol; 2014 Jun; 41(6):1104-11. PubMed ID: 24786924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miR-222-3p is associated with ankylosing spondylitis development and predicts therapeutic efficacy of nonsteroidal anti-inflammatory drugs.
    Jiang G; Wang F; Qi F; Zhang L
    J Biochem Mol Toxicol; 2023 Nov; 37(11):e23475. PubMed ID: 37462336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Serum miR-146a and miR-155 as Novel Noninvasive Complementary Biomarkers for Ankylosing Spondylitis.
    Qian BP; Ji ML; Qiu Y; Wang B; Yu Y; Shi W; Luo YF
    Spine (Phila Pa 1976); 2016 May; 41(9):735-42. PubMed ID: 27128253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miR-214 as a novel biomarker for ankylosing spondylitis.
    Kook HY; Jin SH; Park PR; Lee SJ; Shin HJ; Kim TJ
    Int J Rheum Dis; 2019 Jul; 22(7):1196-1201. PubMed ID: 30729703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquaporin-1 expression as an indicator in evaluating the efficacy of meloxicam in the treatment of ankylosing spondylitis: A comparative study.
    Pan JE; Xiong FL; Chen G; Zhang ZW; Xu YJ
    Biomed Pharmacother; 2017 Nov; 95():1549-1555. PubMed ID: 28950654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients.
    Perez-Sanchez C; Font-Ugalde P; Ruiz-Limon P; Lopez-Pedrera C; Castro-Villegas MC; Abalos-Aguilera MC; Barbarroja N; Arias-de la Rosa I; Lopez-Montilla MD; Escudero-Contreras A; Lopez-Medina C; Collantes-Estevez E; Jimenez-Gomez Y
    Hum Mol Genet; 2018 Mar; 27(5):875-890. PubMed ID: 29329380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nonsteroidal anti-inflammatory drugs on serum proinflammatory cytokines in the treatment of ankylosing spondylitis.
    Yan Y; Guo TM; Zhu C
    Biochem Cell Biol; 2018 Aug; 96(4):450-456. PubMed ID: 29324184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miR-145 as a marker of therapeutic response to anti-TNF therapy in patients with ankylosing spondylitis.
    Prajzlerová K; Komarc M; Forejtová Š; Pavelka K; Vencovský J; Šenolt L; Filková M
    Physiol Res; 2021 Apr; 70(2):255-264. PubMed ID: 33676382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naïve to anti-TNF therapy.
    Reyes-Loyola P; Rodríguez-Henríquez P; Ballinas-Verdugo MA; Amezcua-Castillo LM; Juárez-Vicuña Y; Jiménez-Rojas V; Márquez-Velasco R; Sánchez-Muñoz F; Amezcua-Guerra LM
    Clin Rheumatol; 2019 May; 38(5):1367-1373. PubMed ID: 30911942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Xinfeng capsule improves hypercoagulative state by inhibiting miR-155/NF-κB signaling pathway in patients with active ankylosing spondylitis].
    Fang L; Liu J; Wan L; Zhu F; Tan B; Zhang P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1094-8. PubMed ID: 27412942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial.
    Li Q; Li L; Bi L; Xiao C; Lin Z; Cao S; Liao Z; Gu J
    Trials; 2016 Jul; 17(1):337. PubMed ID: 27449221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study].
    Gaydukova IZ; Khondkaryan EV; Aparkina AV; Rebrov AP
    Ter Arkh; 2017; 89(5):38-45. PubMed ID: 28631697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
    Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
    JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predisposition of six well-characterized microRNAs to syndesmophytes among Chinese patients with ankylosing spondylitis.
    Yang W; Yan X; Xia Q; Tao Q; Gan X; Zhang Y; Chen Z; Kong W
    Mod Rheumatol; 2019 Jan; 29(1):173-180. PubMed ID: 29542383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis.
    Løvendorf MB; Zibert JR; Gyldenløve M; Røpke MA; Skov L
    J Dermatol Sci; 2014 Aug; 75(2):133-9. PubMed ID: 24909097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
    Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAIDs in ankylosing spondylitis.
    Miceli-Richard C; Dougados M
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S65-6. PubMed ID: 12463450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays.
    Zhang C; Bai N; Huang W; Zhang P; Luo Y; Men S; Wen T; Tong H; Wang S; Tian YP
    Ann Hematol; 2016 Oct; 95(11):1833-43. PubMed ID: 27553380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.
    Jafarnezhad-Ansariha F; Yekaninejad MS; Jamshidi AR; Mansouri R; Vojdanian M; Mahmoudi M; Fattahi MJ; Hashemi SN; Rehm BHA; Matsuo H; Esposito E; Cuzzocrea S; Mirshafiey A
    Inflammopharmacology; 2018 Apr; 26(2):375-384. PubMed ID: 28819782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.